BOTW
BIIB icon

Bank of the West’s Biogen BIIB Stock Holding History

Bank of the West’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,553
Closed -$595K – 269
2019
Q3 		$595K Sell
2,553
-949
-27% -$221K 0.07% 189
2019
Q2 		$819K Sell
3,502
-9,335
-73% -$2.16M 0.1% 163
2019
Q1 		$3.04M Sell
12,837
-2,019
-14% -$636K 0.35% 79
2018
Q4 		$4.47M Sell
14,856
-450
-3% -$144K 0.54% 52
2018
Q3 		$5.41M Sell
15,306
-365
-2% -$126K 0.63% 44
2018
Q2 		$4.55M Sell
15,671
-412
-3% -$116K 0.56% 54
2018
Q1 		$4.4M Sell
16,083
-2,345
-13% -$728K 0.55% 56
2017
Q4 		$5.87M Sell
18,428
-3,820
-17% -$1.23M 0.74% 41
2017
Q3 		$6.97M Sell
22,248
-1,127
-5% -$334K 0.88% 33
2017
Q2 		$6.34M Sell
23,375
-464
-2% -$123K 0.82% 33
2017
Q1 		$6.52M Sell
23,839
-19
-0.1% -$5.37K 0.82% 33
2016
Q4 		$6.77M Sell
23,858
-3,775
-14% -$1.12M 0.94% 26
2016
Q3 		$8.65M Sell
27,633
-4,666
-14% -$1.38M 1.19% 19
2016
Q2 		$7.81M Buy
32,299
+2,465
+8% +$650K 1.11% 21
2016
Q1 		$7.77M Buy
29,834
+1,721
+6% +$455K 1.07% 23
2015
Q4 		$8.61M Buy
28,113
+2,053
+8% +$590K 1.2% 21
2015
Q3 		$7.61M Buy
26,060
+5,967
+30% +$1.97M 1.21% 18
2015
Q2 		$8.12M Buy
20,093
+2,447
+14% +$982K 1.16% 19
2015
Q1 		$7.45M Buy
17,646
+8,309
+89% +$3.27M 1.05% 24
2014
Q4 		$3.17M Sell
9,337
-34
-0.4% -$11K 0.46% 73
2014
Q3 		$3.1M Sell
9,371
-71
-0.8% -$23.4K 0.53% 65
2014
Q2 		$2.98M Buy
9,442
+138
+1% +$41.5K 0.46% 80
2014
Q1 		$2.85M Sell
9,304
-292
-3% -$92.7K 0.47% 76
2013
Q4 		$2.68M Sell
9,596
-946
-9% -$245K 0.43% 80
2013
Q3 		$2.54M Sell
10,542
-1,496
-12% -$335K 0.46% 76
2013
Q2 		$2.59M Buy
+12,038
New +$2.57M 0.49% 73

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of the West's BIIB Position: Q4 2019 in Review

Bank of the West sold out of Biogen (BIIB) in Q4 2019, closing a stake of 2,553 shares — an estimated $595K sold.

Bank of the West first reported a position in BIIB in Q2 2013 and held it in 26 quarters. The position peaked at $8.65M in Q3 2016. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Bank of the West reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Bank of the West sold 2,553 Biogen shares in Q4 2019, an estimated $595K.
  • Bank of the West first reported a position in Biogen in Q2 2013 and held it in 26 quarters.
  • Bank of the West's Biogen position peaked at $8.65M in Q3 2016.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Bank of the West's 13F filing for Q4 2019, filed 10 Feb 2020.